Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Myasthenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07596901
What this trial is testing

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Aurinia Pharmaceuticals Inc. 81
Large-scale testing (Phase 3)Looking for participantsNCT05868837
What this trial is testing

Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)

Who this might be right for
Myasthenia Gravis, Generalized
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Large-scale testing (Phase 3)Study completedNCT05514873
What this trial is testing

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 26
Large-scale testing (Phase 3)Looking for participantsNCT06447597
What this trial is testing

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

Who this might be right for
Generalized Myasthenia Gravis
Shanghai Jiaolian Drug Research and Development Co., Ltd 104
Large-scale testing (Phase 3)Looking for participantsNCT06392386
What this trial is testing

Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
argenx 12
Large-scale testing (Phase 3)Study completedNCT00683969
What this trial is testing

Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Hoffmann-La Roche 136
Large-scale testing (Phase 3)Study completedNCT03971422
What this trial is testing

Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 200
Testing effectiveness (Phase 2)Study completedNCT01480596
What this trial is testing

The Evaluation of Belimumab in Myasthenia Gravis (MG)

Who this might be right for
Myasthaenia Gravis
GlaxoSmithKline 40
Testing effectiveness (Phase 2)Study completedNCT03772587
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Momenta Pharmaceuticals, Inc. 68
Large-scale testing (Phase 3)Study completedNCT06471361
What this trial is testing

Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 31
Large-scale testing (Phase 3)Study completedNCT04115293
What this trial is testing

Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Ra Pharmaceuticals, Inc. 174
Large-scale testing (Phase 3)Study completedNCT04225871
What this trial is testing

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 200
Not applicableLooking for participantsNCT06455709
What this trial is testing

Markers of Favorable Response to Complement Inhibitors Therapy

Who this might be right for
Myasthenia Gravis, Generalized
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Large-scale testing (Phase 3)Study completedNCT04818671
What this trial is testing

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
argenx 184
Large-scale testing (Phase 3)Active Not RecruitingNCT06298552
What this trial is testing

Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMGMyasthenia Gravis, Generalized+1 more
argenx 119
Large-scale testing (Phase 3)Study completedNCT04980495
What this trial is testing

An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisMG - Myasthenia GravisgMG
argenx 69
Early research (Phase 1)Not Yet RecruitingNCT06759948
What this trial is testing

An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Chongbo Zhao 18
Large-scale testing (Phase 3)Looking for participantsNCT06193889
What this trial is testing

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia GravisGeneralized Myasthenia Gravis
Kyverna Therapeutics 66
Testing effectiveness (Phase 2)Ended earlyNCT05218096
What this trial is testing

Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisMyasthenia Gravis
Alexion Pharmaceuticals, Inc. 70
Large-scale testing (Phase 3)Looking for participantsNCT07039916
What this trial is testing

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Immunovant Sciences GmbH 231
Next Page